Get the latest bluebird bio Inc. (BLUE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Biotech and PharmaBluebird Bio Stock Is Sliding. The Biotech Plans a Share Offering. Jan. 18, 2023 at 10:40 a.m. ETby Barron's Biotech and PharmaBluebird Bio Gets FDA Approval for $3 Million Gene Therapy, Breaking Its Own Price Record ...
Skip to main content Get the best of TheStreet to your inbox SUBSCRIBE TECH Retail INVESTING MARKETS PERSONAL FINANCE CRYPTO PRO Investing Bitcoin Cannabis Cryptocurrency ETFs Earnings Fixed Income Funds Futures Options Rating REITs Stocks
On this news, bluebird's stock price fell $9.72 per share, or 16.6%, to close at $48.83 per share on November 5, 2020. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, a...
Bluebird Bio Company Info Bluebird Bio is a development-stage biotechnology company focused on gene therapy, gene editing, and cancer immunotherapy. News & Analysis The Fool has written over 300 articles on Bluebird Bio. Featured Article Is Bluebird Bio Stock a Buy? It won't be easy for the...